EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantifying uncertainty of predictions from cancer progression models

Yanren Linda Hu iD, Simon Pfahler iD, Andreas Lösch iD, Stefan Vocht iD, Stefan Hansch iD, Kevin Rupp iD, Niko Beerenwinkel iD, Tilo Wettig iD, Rudolf Schill iD, Rainer Spang iD

Bioinformatics · 2026

DOI: 10.1093/bioinformatics/btag526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, 2026. Verfasst von Yanren Linda Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department for Statistical Bioinformatics, University of Regensburg, Regensburg 93053, Germany. Hauptthemen laut MEDLINE: Neoplasms, Computational Biology. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Swiss National Science Foundation, Swiss Cancer League.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation Cancer progresses through the accumulation of genomic events. Cancer progression models such as Mutual Hazard Networks (MHNs) describe this dynamic, enabling prediction of temporal event positions and patient-specific risks of acquiring mutations. However, current MHN analyses rely on single most likely models and do not quantify the uncertainty inherent to parameter estimation. Assessing forecast stability is essential before using them to anticipate treatment-relevant mutations, adapt targeted therapies, or prioritize monitoring of patients at elevated progression risk. Results We address a key prerequisite for the responsible clinical use of cancer progression models by making MHN-derived predictions uncertainty-aware. We present a Bayesian framework for MHN that uses Markov Chain Monte Carlo to sample from the posterior distributions of model parameters and derived predictions. For practical use we implemented the Random-Walk Metropolis, Metropolis-Adjusted Langevin Algorithm (MALA), and simplified manifold MALA samplers as part of the existing mhn Python package. Only MALA and smMALA were successful in sampling from MHN posteriors, with MALA performing best. While most MHN parameters and predictions showed low posterior variance, a small subset displayed greater variability across the posterior distribution. This differentiation cannot be obtained from a single most likely model, emphasizing the need for uncertainty quantification, especially in clinical contexts. As an illustrative example, posterior sampling identified a subgroup of STK11$-$, KRAS$+$ lung adenocarcinoma patients with a high predicted short-term risk—with low variance across posterior samples—to develop an STK11 mutation. This subgroup exhibited poorer survival under immunotherapy, resembling patterns observed in STK11+ patients. Availability and implementation Our implementation is part of version 1.2.0 of the mhn package (https://github.com/spang-lab/LearnMHN). All analyses including the code to produce all figures in this article can be found under https://github.com/huy29433/MCMC-sampling-for-MHN (https://doi.org/10.5281/zenodo.21160219).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsComputational BiologyHumansUncertaintyDisease ProgressionAlgorithmsBayes TheoremMarkov ChainsMutationPrediction Algorithms

Autor:innen und Institutionen

  • Department for Statistical Bioinformatics, University of Regensburg, Regensburg 93053, Germany.
  • Department of Physics, University of Regensburg, Regensburg 93040, Germany.
  • Department of Biosystems Science and Engineering, ETH Zürich, Basel 4056, Switzerland.

ORCID-Profile: Yanren Linda Hu, Simon Pfahler, Andreas Lösch, Stefan Vocht, Stefan Hansch, Kevin Rupp, Niko Beerenwinkel, Tilo Wettig, Rudolf Schill, Rainer Spang

Förderung

  • German Research Foundation
  • Swiss National Science Foundation
  • Swiss Cancer League
  • Free State of Bavaria [Marianne-Plehn-Program

Zitieren

APA

Hu, Y. L., Pfahler, S., Lösch, A., Vocht, S., Hansch, S., Rupp, K., Beerenwinkel, N., Wettig, T., Schill, R., & Spang, R. (2026). Quantifying uncertainty of predictions from cancer progression models. Bioinformatics. https://doi.org/10.1093/bioinformatics/btag526

Vancouver

Hu YL, Pfahler S, Lösch A, Vocht S, Hansch S, Rupp K, et al. Quantifying uncertainty of predictions from cancer progression models. Bioinformatics. 2026. doi:10.1093/bioinformatics/btag526

BibTeX
@article{Hu2026,
  author = {Hu, Yanren Linda and Pfahler, Simon and Lösch, Andreas and Vocht, Stefan and Hansch, Stefan and Rupp, Kevin and Beerenwinkel, Niko and Wettig, Tilo and Schill, Rudolf and Spang, Rainer},
  title = {Quantifying uncertainty of predictions from cancer progression models},
  journal = {Bioinformatics},
  year = {2026},
  doi = {10.1093/bioinformatics/btag526}
}
Kostenlos starten →